- Home
- VOR vs RERE Comparison
VOR vs RERE Comparison
Compare VOR & RERE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VOR | RERE |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 855.0M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | VOR | RERE |
|---|---|---|
| Price | $23.66 | $4.53 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $45.33 | N/A |
| AVG Volume (30 Days) | ★ 946.2K | 854.9K |
| Earning Date | 05-11-2026 | 05-19-2026 |
| Dividend Yield | N/A | ★ 2.27% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $25.70 |
| Revenue Next Year | N/A | $22.93 |
| P/E Ratio | ★ N/A | $34.57 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.62 | $3.50 |
| 52 Week High | $49.95 | $6.47 |
Technical Indicators
Market Signals| Indicator | VOR | RERE |
|---|---|---|
| Relative Strength Index (RSI) | 71.43 | 60.45 |
| Support Level | $11.62 | $4.31 |
| Resistance Level | N/A | $5.20 |
| Average True Range (ATR) | 1.54 | 0.18 |
| MACD | 0.28 | 0.05 |
| Stochastic Oscillator | 98.66 | 96.32 |
Price Performance
Historical ComparisonAbout VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
About RERE ATRenew Inc.
ATRenew Inc is a pre-owned consumer electronics transactions and services platform in China. The majority of its revenue is derived from online product sales of phones and other consumer electronics goods through its platforms PJT Marketplace and Paipai Marketplace. The Company's principal operations and geographic markets are in the People's Republic of China.